companydata.dkcompanydata.dk

AGC Biologics A/S: Financial statements 2015

CVR: 25950941

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

AGC Biologics A/S (CVR 25950941) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 320,466,000 and a net result of DKK 8,373,000 compared with DKK 3,181,000 the year before. That is an increase of 3% compared with the year before. The profit margin was 2.6%. Equity in the 2015 report amounted to DKK 147,895,000. The solvency ratio was 36.6%. The company had 209 employees in the financial year.

Revenue
DKK 320,466,000
Gross Profit
DKK 62,337,000
Profit/Loss
DKK 8,373,000
Equity
DKK 147,895,000
Total Assets
DKK 404,229,000
Employees
209

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015320.5M62.3M8.4M147.9M209
2014311.1M45.8M3.2M139.5M199
2013-37.2M-128K136.3M185

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is AGC Biologics A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

AGC Biologics A/S: The 2014 annual report is outJun 19, 2015

AGC Biologics A/S has published its annual report for 2014. Revenue came to DKK 311,091,000, and the net result was DKK 3,181,000.

About AGC Biologics A/S

AGC Biologics A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named CMC BIOLOGICS A/S and CMC BIOPHARMACEUTICALS A/S. The management consists of Kasper Møller. The board consists of Tadashi Murano (chair), Alberto Santagostino, Kasper Møller and Mai Iwaya. The company is owned by Asahi Glass Co., Ltd.. The company has 1,503 employees (2026). In 2025, the company reported revenue of DKK 1,959,639,000 and a net result of DKK -328,010,000 compared with DKK -115,005,000 the year before. Equity in the 2025 report amounted to DKK 312,021,000.

Source: annual report 2025, Danish Business Authority